RDGT
Ridgetech Inc.
Medical - Distribution
Market Cap$382.00
5Y Perf.-99.4%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
RDGT vs WGRX
Revenue, margins, valuation, and 5-year total return — side by side.
WGRX
Wellgistics Health, Inc.
Medical - Distribution
Market Cap$8M
5Y Perf.-96.7%
RDGT vs WGRX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | RDGT | WGRX |
|---|---|---|
| Industry | Medical - Distribution | Medical - Distribution |
| Market Cap | $382.00 | $8M |
| Revenue (TTM) | $259M | $6M |
| Net Income (TTM) | $7M | $-73M |
| Gross Margin | 8.3% | 4.1% |
| Operating Margin | -1.8% | -12.1% |
| Total Debt | $10M | $25M |
| Cash & Equiv. | $13M | $1M |
RDGT vs WGRX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
RDGT
WGRX
| Stock | Feb 25 | May 26 | Return |
|---|---|---|---|
| Ridgetech Inc. (RDGT) | 100 | 0.6 | -99.4% |
| Wellgistics Health,… (WGRX) | 100 | 3.3 | -96.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RDGT vs WGRX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: RDGT leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Wellgistics Health, Inc. is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
RDGT
Ridgetech Inc.
The Growth Play
RDGT carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth -22.4%, EPS growth 162.8%, 3Y rev CAGR -10.0%
- Lower volatility, beta 1.10, Low D/E 35.0%, current ratio 1.74x
- -22.4% revenue growth vs WGRX's -91.8%
Best for: growth exposure and sleep-well-at-night
WGRX
Wellgistics Health, Inc.
The Income Pick
WGRX is the clearest fit if your priority is income & stability and long-term compounding.
- beta 0.96
- -97.7% 10Y total return vs RDGT's -100.0%
- Beta 0.96, current ratio 0.40x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | RDGT | -22.4% revenue growth vs WGRX's -91.8% |
| Quality / Margins | RDGT | 2.6% margin vs WGRX's -13.0% |
| Stability / Safety | WGRX | Beta 0.96 vs RDGT's 1.10 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | WGRX | -98.0% vs RDGT's -99.1% |
| Efficiency (ROA) | RDGT | 8.7% ROA vs WGRX's -138.4%, ROIC -2.4% vs -32.2% |
RDGT vs WGRX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2024
RDGT vs WGRX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLRDGTLAGGINGWGRX
WGRXWellgistics Health, I…
2leads
RDGTRidgetech Inc.
3leads
6 Total Categories
CATEGORYLEADERvs WGRXMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
RDGT6/6
Valuation MetricsMultiples, price ratios, and targets
RDGT2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
RDGT7/7
Total Returns1Y, 3Y, 5Y total returns with dividends
WGRX6/6
Risk & VolatilityBeta, volatility, and downside exposure
WGRX2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
RDGT leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RDGT is the larger business by revenue, generating $259M annually — 46.0x WGRX's $6M. RDGT is the more profitable business, keeping 2.6% of every revenue dollar as net income compared to WGRX's -13.0%. On growth, RDGT holds the edge at -11.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | RDGTRidgetech Inc. | WGRXWellgistics Healt… |
|---|---|---|
| RevenueTrailing 12 months | $259M | $6M |
| EBITDAEarnings before interest/tax | $2M | -$65M |
| Net IncomeAfter-tax profit | $7M | -$73M |
| Free Cash FlowCash after capex | -$10M | -$7M |
| Gross MarginGross profit ÷ Revenue | +8.3% | +4.1% |
| Operating MarginEBIT ÷ Revenue | -1.8% | -12.1% |
| Net MarginNet income ÷ Revenue | +2.6% | -13.0% |
| FCF MarginFCF ÷ Revenue | -3.7% | -130.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -11.7% | -80.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +97.5% | -11.8% |
RDGT leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
RDGT leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | RDGTRidgetech Inc. | WGRXWellgistics Healt… |
|---|---|---|
| Market CapShares × price | $382 | $8M |
| Enterprise ValueMkt cap + debt − cash | -$2M | $32M |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | -0.68x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | -0.48x | — |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 0.44x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.68x |
| Price / FCFMarket cap ÷ FCF | 0.00x | — |
RDGT leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
RDGT leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
RDGT delivers a 29.1% return on equity — every $100 of shareholder capital generates $29 in annual profit, vs $-11 for WGRX. RDGT carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to WGRX's 3.73x.
| Metric | RDGTRidgetech Inc. | WGRXWellgistics Healt… |
|---|---|---|
| ROE (TTM)Return on equity | +29.1% | -10.8% |
| ROA (TTM)Return on assets | +8.7% | -138.4% |
| ROICReturn on invested capital | -2.4% | -32.2% |
| ROCEReturn on capital employed | -4.1% | -73.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.35x | 3.73x |
| Net DebtTotal debt minus cash | -$2M | $24M |
| Cash & Equiv.Liquid assets | $13M | $1M |
| Total DebtShort + long-term debt | $10M | $25M |
| Interest CoverageEBIT ÷ Interest expense | — | -10.95x |
RDGT leads this category, winning 7 of 7 comparable metrics.
Total Returns (Dividends Reinvested)
WGRX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WGRX five years ago would be worth $232 today (with dividends reinvested), compared to $0 for RDGT. Over the past 12 months, WGRX leads with a -98.0% total return vs RDGT's -99.1%. The 3-year compound annual growth rate (CAGR) favors WGRX at -71.5% vs RDGT's -91.6% — a key indicator of consistent wealth creation.
| Metric | RDGTRidgetech Inc. | WGRXWellgistics Healt… |
|---|---|---|
| YTD ReturnYear-to-date | -99.6% | -79.7% |
| 1-Year ReturnPast 12 months | -99.1% | -98.0% |
| 3-Year ReturnCumulative with dividends | -99.9% | -97.7% |
| 5-Year ReturnCumulative with dividends | -100.0% | -97.7% |
| 10-Year ReturnCumulative with dividends | -100.0% | -97.7% |
| CAGR (3Y)Annualised 3-year return | -91.6% | -71.5% |
WGRX leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
WGRX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WGRX is the less volatile stock with a 0.96 beta — it tends to amplify market swings less than RDGT's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | RDGTRidgetech Inc. | WGRXWellgistics Healt… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 0.96x |
| 52-Week HighHighest price in past year | $760.50 | $7.04 |
| 52-Week LowLowest price in past year | $1.23 | $0.08 |
| % of 52W HighCurrent price vs 52-week peak | +0.2% | +1.3% |
| RSI (14)Momentum oscillator 0–100 | 32.8 | 31.2 |
| Avg Volume (50D)Average daily shares traded | 59.4M | 13.8M |
WGRX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | RDGTRidgetech Inc. | WGRXWellgistics Healt… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
RDGT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). WGRX leads in 2 (Total Returns, Risk & Volatility).
Best OverallRidgetech Inc. (RDGT)Leads 3 of 6 categories
Loading custom metrics...
RDGT vs WGRX: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — RDGT or WGRX?
Over the past 5 years, Wellgistics Health, Inc.
(WGRX) delivered a total return of -97. 7%, compared to -100. 0% for Ridgetech Inc. (RDGT). Over 10 years, the gap is even starker: WGRX returned -97. 7% versus RDGT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — RDGT or WGRX?
By beta (market sensitivity over 5 years), Wellgistics Health, Inc.
(WGRX) is the lower-risk stock at 0. 96β versus Ridgetech Inc. 's 1. 10β — meaning RDGT is approximately 15% more volatile than WGRX relative to the S&P 500. On balance sheet safety, Ridgetech Inc. (RDGT) carries a lower debt/equity ratio of 35% versus 4% for Wellgistics Health, Inc. — giving it more financial flexibility in a downturn.
03Which is growing faster — RDGT or WGRX?
On earnings-per-share growth, the picture is similar: Ridgetech Inc.
grew EPS 162. 8% year-over-year, compared to -116. 7% for Wellgistics Health, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — RDGT or WGRX?
Ridgetech Inc.
(RDGT) is the more profitable company, earning 8. 5% net margin versus -37. 8% for Wellgistics Health, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RDGT leads at -0. 9% versus -33. 9% for WGRX. At the gross margin level — before operating expenses — WGRX leads at 9. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — RDGT or WGRX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is RDGT or WGRX better for a retirement portfolio?
For long-horizon retirement investors, Wellgistics Health, Inc.
(WGRX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 96)). Both have compounded well over 10 years (WGRX: -97. 7%, RDGT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between RDGT and WGRX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(RDGT: -11.7% · WGRX: -80.9%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.